A U.K. woman, who was diagnosed with a rare cancer, recalls having eight organs removed in what she described as 'the mother ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

SHRA-1921 is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Metastatic Breast Cancer.

The technology, known also as AI , can correctly spot tiny tumours, called lesions, on ultrasound images of the ovaries, ...

Since its discovery in the 1990s, "programmed cell death protein 1," or PD-1, has been regarded as a leading target in cancer treatments.

In the lead-up to Sheila Hailstone’s cancer diagnosis, months before she even noticed a breast lump herself, her dog,. One ...

Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...

Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...

In an extremely rare case, a doctor operating on a cancer patient in Germany accidentally 'transplanted' the disease into ...

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform ...

RECORD numbers of cancers are being diagnosed early when they are more curable, NHS figures show. Nearly six in ten of the 13 ...